Clinical Trials List
Protocol NumberS4-13-001 EX
Not yet recruiting
2021-05-01 - 2024-04-30
Phase II
Terminated1
-
Trial Applicant
AMAREX TAIWAN, LLC TAIWAN BRANCH (U.S.A.)
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Tai-Jan Chiu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
1 participants
-
Global
0 participants
